ArticleProceedings of the National Academy of Sciences of the United States of America2026
Shihan Huo, Min Ma, Shuo Qian, Ming Zhang, Jie Pu, Xiaoyu Zhu, Sailee Rasam, Tara Barone, Robert Plunkett, Chi Zhou and 1 more
Abstract read
In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors.
Shihan Huo *Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Min Ma *Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Shuo QianDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.ORCID 0000-0002-9038-9704 Ming ZhangDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Jie PuDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Xiaoyu ZhuDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Sailee RasamDepartment of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203.
Tara BaroneDepartment of Neuro-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203.ORCID 0009-0002-2004-5022 Robert PlunkettDepartment of Neuro-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203.ORCID 0009-0009-9388-9876 Chi ZhouDepartment of Industrial and Systems Engineering, State University of New York at Buffalo, Buffalo, NY 14214.
Jun QuDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.ORCID 0000-0002-1346-6809 Funding
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical ApplicationsU01DK137113 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI Wei-Jun Qian, Jun Qu · 2023 to 2026
$3.8MHHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK137113NIDDK NIH HHS U01 DK137113
6 · The paper itselfAbstract
Whole-tissue level spatial proteomics provides critical insights into region-specific biological regulations but remains challenging. Previously, we introduced the micro-scaffold assisted spatial proteomics (MASP) concept for whole-tissue mapping. However, this prototype required substantial development in spatial resolution, practicality, and throughput for practical application. Here we present a next-generation MASP technique (
Indexed as
Antibodies, MonoclonalBrainProteomeProteomicsAnimalsLiquid Chromatography-Mass SpectrometryMiceAntibodies, MonoclonalProteomeaccurate protein distributionmAb intrabrain distributionspatial proteomicswhole-tissue mapping
Identifiers
PMID42691083
PMCPMC13552876
What OpenQuestion holds
Textmetadata
Read underepoch 390